Importantly, the specific blockade of GAL-3 in MM cells further increased proliferation of LAG3 expressing XBP1/CD138/CS1-CTL (Fig. 8C), suggesting an alternative escape mechanism after anti-GAL-3 therapy in MM patients. Here, XBP1 is linked to Miyoshi myopathy.